BackAmneal Pharmaceuticals Overview
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

Amneal Pharmaceuticals Target Price

See Amneal Pharmaceuticals's analyst price targets ($20) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$18.48

Average Target Price

$19.756.9% upside

4 analysts in the last 4 months

High: $23 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-31Goldman Sachs$2113.6% upsideOpen
2026-07-15UBSAshwani Verma$2324.5% upsideOpen
2026-05-20BarclaysGlen Santangelo$1613.4% downsideOpen
2026-04-17UBSAshwani Verma$192.8% upsideOpen
2026-03-02Truist FinancialLes Sulewski$178% downsideOpen
2026-01-07Truist Financial$1518.8% downsideOpen
2025-12-08Barclays$1518.8% downsideOpen
2025-03-03Barclays$1140.5% downsideOpen
2024-11-11Piper SandlerDavid Amsellem$1140.5% downsideOpen
2024-10-02Truist FinancialLes Sulewski$1235.1% downsideOpen
2024-10-01Truist FinancialLes Sulewski$1045.9% downsideOpen
2024-05-03Truist FinancialLes Sulewski$951.3% downsideOpen
2024-03-21Piper SandlerDavid Amsellem$856.7% downsideOpen
2022-08-08Goldman Sachs$478.4% downsideOpen

Amneal Pharmaceuticals (AMRX) FAQ

Amneal Pharmaceuticals (AMRX) currently reports a target price of $20. Use the charts on this page to explore Amneal Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for Amneal Pharmaceuticals is $20, about 6.9% upside from the current share price of $18.48. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $20, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Amneal Pharmaceuticals, and consider following AMRX for alerts when major investors trade the stock.

Amneal Pharmaceuticals is classified in the Healthcare sector. On target price, it currently shows $20. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AMRX with unrelated industries.